About "PK repeats" [Software]

posted by Ohlbe – France, 2010-10-21 19:32 (5713 d 22:43 ago) – Posting: # 6073
Views: 18,197

Dear Helmut,

❝ But I must confess that I don't see the rationale] behind 'a ban on BE

❝ studies'.


The rationale is not scientific, it's just paranoia. The fear is that the lab could be tempted to repeat the assay if bioequivalence is not demonstrated, particularly for Cmax, to try and get "better" results. No reason to do such a thing in BA trials when developing a new drug.

There is a lot of regulatory paranoia regarding BE trials, but one has to admit that this paranoia is fed by inspection results. Remember the results of French inspections which were presented at the EGA meeting some years ago (2007 I think): basically, critical observations in half of the dossiers inspected, including fraud or some level of data manipulation in one quarter of the dossiers inspected.

Best regards
Ohlbe

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
117 visitors (0 registered, 117 guests [including 25 identified bots]).
Forum time: 18:16 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5